Gerard J. Platenburg
Founder chez PROQR THERAPEUTICS N.V.
Profil
Gerard J.
Platenburg is the founder of Prosensa Holding NV, which was founded in 2002.
He held the title of Chief Executive & Development Officer from 2002 to 2009.
He is also the founder of ProQR Therapeutics NV, which was founded in 2012.
Currently, he holds the title of Chief Scientific Officer at ProQR Therapeutics NV.
Mr. Platenburg's former job includes being the Chief Executive Officer at ISA Pharmaceuticals BV from 2009 to 2014.
He also worked at Pharming NV as a Principal.
Mr. Platenburg obtained his graduate degree from the University of Leiden in 1987.
Postes actifs de Gerard J. Platenburg
| Sociétés | Poste | Début |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Founder | 21/02/2012 |
Anciens postes connus de Gerard J. Platenburg
| Sociétés | Poste | Fin |
|---|---|---|
ISA Pharmaceuticals BV
 ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Chief Executive Officer | 01/01/2014 |
| PROSENSA HOLDING NV | Chief Executive Officer | 01/05/2009 |
Pharming NV
 Pharming NV Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Pharming NV is a Belgian company that develops therapeutic products for the treatment of a range of medical indications. The private company is based in Geel, Belgium. Pharming was acquired by Genzyme Corp., a subsidiary of Sanofi from Pharming Group NV on October 30, 2001. | Corporate Officer/Principal | - |
Formation de Gerard J. Platenburg
| University of Leiden | Graduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PROQR THERAPEUTICS N.V. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Pharming NV
Pharming NV Miscellaneous Commercial ServicesCommercial Services Part of Sanofi, Pharming NV is a Belgian company that develops therapeutic products for the treatment of a range of medical indications. The private company is based in Geel, Belgium. Pharming was acquired by Genzyme Corp., a subsidiary of Sanofi from Pharming Group NV on October 30, 2001. | Commercial Services |
Prosensa Holding NV
 Prosensa Holding NV BiotechnologyHealth Technology Prosensa Holding NV engages in the development of ribonucleic acid-modulating, or RNA-modulating, therapeutics for the treatment of genetic disorders. The company focuses on rare neuromuscular and neurodegenerative disorders, Duchenne muscular dystrophy, myotonic dystrophy and Huntington's disease. It has developed a portfolio of clinical and pre-clinical RNA-based drug candidates. Prosensa's current clinical portfolio is focused on the treatment of Duchenne Muscular Dystrophy. The company was founded in 2002 and is headquartered in Leiden, the Netherlands. | Health Technology |
ISA Pharmaceuticals BV
ISA Pharmaceuticals BV Pharmaceuticals: MajorHealth Technology ISA Pharmaceuticals BV operates as a clinical-stage immunotherapy company. The firm develops novel therapeutic vaccines for cancer and infectious diseases. Its product portfolio builds on its proprietary SLP-technology (Synthetic Long Peptide) for the development of therapeutic vaccines. The firm holds the exclusive rights to LUMC's patent families for amongst others, the development of therapeutic vaccines. The company was founded by Cornelis J. M. Melief in 2004 and is headquartered in Leiden, the Netherlands. | Health Technology |
